Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: A retrospective data analysis

World Journal of Urology

Volumn 30, Issue 3, 2012, Pages 341-346

  Aigner, Friedrich ^a   Schäfer, Georg ^a,b   Steiner, Eberhard ^a   Jaschke, Werner ^a   Horninger, Wolfgang ^a   Herrmann, Thomas R W ^c   Nagele, Udo ^d   Halpern, Ethan J ^e   Frauscher, Ferdinand ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Thomas Jefferson University ^*  (Austria)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Biopsy; Contrast media; Prostate; Prostatic neoplasms; Sonoelastography; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD; COMPUTER SYSTEM; ECHOGRAPHY; ELASTOGRAPHY; EVALUATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COMPUTER SYSTEMS; ELASTICITY IMAGING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84861645007     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0809-6     Document Type: Article

References (18)

1. Gómez Veiga F, Ponce Reixa J, Barbagelata López A, Fernández Rosado E, Gonzaåez Martiñ M (2006) Current role of PSA and other markers in the diagnosis of prostate cancer. Arch Esp Urol 59: 1069-1082.
2. Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW (1998) Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 52: 808-813.
3. Loch T (2011) Prostate cancer diagnostics: innovative imaging in case of multiple negative biopsies. World J Urol 29: 607-614.
4. Kurhanewicz J, Vigneron D, Carroll P, Coakley F (2008) Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18: 71-77.
5. Schlemmer HP (2010) Multiparametric MRI of the prostate: method for early detection of prostate cancer? Rofo 182: 1067-1075.
6. Krouskop TA, Wheeler TM, Kallel F, Garra BS, Hall T (1998) Elastic moduli of breast and prostate tissues under compression. Ultrason Imaging 20: 260-274.
7. Aigner F, Pallwein L, Mitterberger M, Pinggera GM, Mikuz G, Horninger W et al (2009) Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 103: 458-463.
8. Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schönitzer D et al (2001) Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58: 417-424.
9. Thompson IM, Ernst JJ, Gangai MP, Spence CR (1984) Adenocarcinoma of the prostate: results of routine urological screening. J Urol 132: 690-692.
10. van Moorselaar RJ, Voest EE (2002) Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 197: 239-250.
11. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4. 0 ng per millilitre. N Engl J Med 350: 2239-2246.
12. Djavan B, Mazal P, Zlotta A, Wammack R, Ravery V, Remzi M et al (2001) Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 47: 111-117.
13. Philip J, Manikandan R, Javlé P, Foster CS (2009) Prostate cancer diagnosis: should patients with prostate specific antigen > 10 ng/mL have stratified prostate biopsy protocols? J Urol 181: 1922-1925.
14. Simon J, Kuefer R, Bartsch G Jr, Volkmer BG, Hautmann RE, Gottfried HW (2008) Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int 102: 459-462.
15. Grabski B, Baeurle L, Loch A, Wefer B, Paul U, Loch T (2011) Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies. World J Urol 29: 573-579.
16. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML (2008) Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 53: 976-981.
17. Anastasiadis AG, Lichy MP, Nagele U, Kuczyk MA, Merseburger AS, Hennenlotter J et al (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50: 738-748.
18. Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D et al (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183: 520-527.